Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MTNR1A | P48039 | 3/20 | 0.42 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.42 |
| ▸ | ADAMTS4 | O75173 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.40 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | MME | P08473 | 2/20 | 0.38 |
| ▸ | LTA4H | P09960 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7805609 | 1.00 | MTNR1A (0.42) | MTNR1AMTNR1BADAMTS4LMNASMN1; SMN2 | |
| SCHEMBL6489470 | 1.00 | MTNR1A (0.42) | MTNR1AMTNR1BADAMTS4LMNASMN1; SMN2 | |
| SCHEMBL11571322 | 0.83 | CYP2C19 (0.50) | LMNASMN1; SMN2TSHRL3MBTL1 | |
| SCHEMBL19248316 | 0.81 | LMNA (0.46) | MTNR1AMTNR1BADAMTS4LMNASMN1; SMN2 | |
| SCHEMBL19248314 | 0.81 | LMNA (0.46) | MTNR1AMTNR1BADAMTS4LMNASMN1; SMN2 | |
| SCHEMBL11569356 | 0.80 | SMN1; SMN2 (0.49) | MTNR1AMTNR1BLMNASMN1; SMN2MEN1 | |
| SCHEMBL11569642 | 0.78 | KMT2A (0.44) | LMNASMN1; SMN2HTTMEN1KMT2A | |
| SCHEMBL9912493 | 0.76 | TDP1 (0.42) | MTNR1AMTNR1BLMNASMN1; SMN2TSHR | |
| SCHEMBL4560594 | 0.73 | MME (0.42) | MTNR1AMTNR1BHTTKMT2AL3MBTL1 | |
| SCHEMBL4560596 | 0.73 | MME (0.42) | MTNR1AMTNR1BHTTKMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024043313-A1 | REVERSIBLE THERMOCHROMIC COMPOSITION, MICROENCAPSULATED PIGMENT USING SAID REVERSIBLE THERMOCHROMIC COMPOSITION, WRITING TOOL, AND TOY | 三菱ケミカル株式会社 | 2024-02-29 | — | — | WO | disclosed |
| US-6906224-B2 | Process for producing α-aminoketones | AJINOMOTO CO., INC. (JP) | 2005-06-14 | — | — | US | disclosed |
| US-20040210089-A1 | Process for producing alpha-aminoketones | AJINOMOTO CO., INC. (JP) | 2004-10-21 | — | — | US | disclosed |
| US-6696571-B2 | REACTING A 3-OXAZOLIDIN-5-ONE DERIVATIVE WITH A HALOMETHYL LITHIUM AND THEN TREATING WITH AN ACID | AJINOMOTO CO., INC. (JP) | 2004-02-24 | — | — | US | disclosed |
| US-20030100796-A1 | Process for producing alpha-aminoketones | AJINOMOTO CO., INC. (JP) | 2003-05-29 | — | — | US | disclosed |
| US-6570039-B2 | Oxazolidine compounds as chemical intermediates | AJINOMOTO CO., INC. (JP) | 2003-05-27 | — | — | US | disclosed |
| US-20020035288-A1 | Process for producing alpha-aminoketones | AJINOMOTO CO., INC. (JP) | 2002-03-21 | — | — | US | disclosed |
| WO-1992022313-A1 | RENIN INHIBITING COMPOUNDS | ABBOTT LABORATORIES (US) | 1992-12-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040210089-A1 | Process for producing alpha-aminoketones | AAAS, BCKDK, KHK | MTNR1A 4694/4885MTNR1B 4003/4885ADAMTS4 3549/4885 |
| US-20020035288-A1 | Process for producing alpha-aminoketones | AAAS, BCKDK, KHK | MTNR1A 4694/4885MTNR1B 4003/4885ADAMTS4 3549/4885 |
| US-20030100796-A1 | Process for producing alpha-aminoketones | AAAS, BCKDK, KHK | MTNR1A 4694/4885MTNR1B 4003/4885ADAMTS4 3549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.